The U. Food and Drug Administration today approved Descovy emtricitabine mg and tenofovir alafenamide 25 mg in at-risk adults and adolescents weighing at least 35kg for HIV-1 pre-exposure prophylaxis PrEP to reduce the risk of HIV-1 infection from sex, excluding those who have receptive vaginal sex. Descovy is not indicated in individuals at risk of HIV-1 infection from receptive vaginal sex because the effectiveness in this population has not been evaluated. This opportunity to eliminate new HIV infections in our nation seeks to provide our hardest-hit communities with additional expertise, technology and resources required to address the HIV epidemic.
Primary HIV Infection Associated with Oral Transmission
HIV and Oral Sex, what you should know
Participants: Susan P. Buchbinder, MD; Frederick M. Hecht, MD; Jeffrey D. Our goal today is to address three specific questions that have remained controversial throughout the AIDS epidemic. First, based on available scientific evidence, what is the risk of HIV transmission to an HIV-uninfected person who performs oral sex on an insertive male partner who is HIV positive?
I chose oral sex 'cause I thought there was no significant risk of getting HIV in that way. She started with a blowjob but after less then 60 seconds I decided to stop her. During this time I didn't have an erection and actually, I was far away from getting there.
Oral sex involves using your mouth and tongue to stimulate your partner for sexual pleasure. But is oral sex safe or are you at risk of catching a sexually transmitted infection STI? Oral sex is now widely practised in all types of sexual relationships.